Non-Invasive Biomarkers: Key to Better Pancreatic Cancer OutcomesByAjay Goel, PhD, AGAFJanuary 24th 2025Ajay Goel, PhD, AGAF, discusses how the development and validation of novel non-invasive biomarkers can improve early detection and ultimately impact patient outcomes for patients.